SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000921895-10-000169
Filing Date
2010-02-09
Accepted
2010-02-09 16:48:05
Documents
2

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO THE SCHEDULE 13G sc13ga200322inh_02012010.htm SC 13G/A 233617
2 JOINT FILING AGREEMENT ex991to13ga200322inh_020110.htm EX-99.1 31066
  Complete submission text file 0000921895-10-000169.txt   266724
Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice

Mailing Address 9005 WESTSIDE PARKWAY ALPHARETTA GA 30004
Business Address 9005 WESTSIDE PARKWAY ALPHARETTA GA 30004 678-746-1100
INHIBITEX, INC. (Subject) CIK: 0001274913 (see all company filings)

IRS No.: 742708737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-79900 | Film No.: 10584934
SIC: 2836 Biological Products, (No Diagnostic Substances)